Image (1e5a0f45 86aa 498a 9cc3 9f7acc210ed6 01)
Chemical structure diagram of the active ingredient Theophylline, showing its molecular framework.*
Theophylline Tablet, Extended Release
Product Images NDC 72578-174
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 72578-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Viona Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
300 mg (1e5a0f45 86aa 498a 9cc3 9f7acc210ed6 02)
Label for Theophylline Extended-Release Tablets 300 mg by Viona Pharmaceuticals Inc. The label indicates 100 tablets per container, Rx only. It includes storage directions, child-resistant packaging information, manufacturer (Zydus Lifesciences Ltd., India), and distributor details (Viona Pharmaceuticals Inc., Cranford, NJ).*
450 mg (1e5a0f45 86aa 498a 9cc3 9f7acc210ed6 03)
Theophylinne Extended-Release Tablets 450 mg, bottle label for 100 tablets by Viona Pharmaceuticals Inc. The label includes dosage strength, NDC number 72578-174-01, storage instructions, child-resistant packaging notice, and manufacturing details by Zydus Lifesciences Ltd, India. The tablets are uncoated, extended-release form, prescription only.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
